Nepal blacklists 16 Indian pharma cos : The Tribune India

Join Whatsapp Channel

Nepal blacklists 16 Indian pharma cos

Says failed to comply with WHO norms

Nepal blacklists 16 Indian pharma cos


PTI

Kathmandu, December 20

Nepal’s drug regulatory authority has blacklisted 16 Indian pharmaceutical companies, including Divya Pharmacy which manufactures yoga guru Ramdev’s Patanjali products, stating that they failed to comply with the World Health Organisation’s (WHO) drug-manufacturing standards.

Divya Pharmacy one of them

Besides Divya Pharmacy, the list includes Radiant Parenterals Ltd, Mercury Laboratories Ltd, Alliance Biotech, Captab Biotec, Aglowmed Ltd, Zee Laboratories, Daffodils Pharmaceuticals, GLS Pharma, Unijules Life Science, Concept Pharmaceuticals, Shree Anand Life Sciences, IPCA Laboratories, Cadila Healthcare Ltd, Dial Pharmaceuticals and Mackur Laboratories

The Department of Drug Administration, in a notice issued on December 18, asked the local agents in Nepal, which have been supplying these medicines, to immediately recall these.

According to the notice issued by the department, the medicines manufactured by the listed companies cannot be imported or distributed in Nepal.

The list of the companies that do not comply with the WHO standards was published after an inspection of the manufacturing facilities of the pharmaceutical companies that had applied to export their products to Nepal, according to department officials.

In April and July this year, the department sent a team of drug inspectors to India to inspect the manufacturing facilities of pharmaceutical companies that had applied to supply their products to Nepal.

Besides Divya Pharmacy, the list includes Radiant Parenterals Ltd, Mercury Laboratories Ltd, Alliance Biotech, Captab Biotec, Aglowmed Ltd, Zee Laboratories, Daffodils Pharmaceuticals, GLS Pharma, Unijules Life Science, Concept Pharmaceuticals, Shree Anand Life Sciences, IPCA Laboratories, Cadila Healthcare Ltd, Dial Pharmaceuticals and Mackur Laboratories.

Similarly, the department, in another notice issued on December 19, asked the distributors to recall 500 ml and 5-litre hand sanitisers manufactured by India’s Global Healthcare. The department has asked the organisations concerned not to use, sell or distribute the hand sanitiser.

The development comes close on the heels of a controversy over the alleged link of cough syrups, manufactured by a firm in Haryana's Sonepat, to the death of over 66 children in Gambia. The World Health Organisation, had in October this year, issued a medical product alert for the four "contaminated" paediatric medicines.


Top News

Supreme Court to deliver verdict on petitions challenging nullification of Article 370 on Monday

Supreme Court to deliver verdict on petitions challenging nullification of Article 370 on Monday

Five-judge Constitution Bench of CJI DY Chandrachud will del...

Centre denies ‘secret memo’ targeting Sikh Separatists abroad

Centre denies ‘secret memo’ targeting Sikh Separatists abroad

Work of Pak intelligence; those who amplify such fake news d...

Vishnu Deo Sai to be new chief minister of Chhattisgarh

From village panch to top man: Tribal leader Vishnu Deo Sai is Chhattisgarh’s 4th chief minister

Chhattisgarh state BJP chief Arun Sao and Kawardha MLA likel...

‘Main Nahin, Hum’: INDIA bloc to work on this motto at next strategy meet to take on PM Modi

INDIA bloc to meet on December 19 in Delhi, to work on ‘Main Nahin, Hum’ motto to take on Modi

Meeting is being held in the backdrop of the Congress’ poor ...

BSP chief Mayawati names nephew Akash Anand as her political successor

BSP chief Mayawati names nephew Akash Anand as her political successor

Mayawati makes the announcement at party meet in Lucknow


Cities

View All